The Anterior Commissure in Laryngeal Cancer

Sunday, September 29, 2024

8:00 AM – 9:00 AM EDT

Location: MBCC, Ocean Drive B

CME/MOC Credit: 1

Disclosure(s):

Rogerio A. Dedivitis, MD, PhD:

faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

Luiz P. Kowalski, MD:

faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

Fernando L. Dias, MD, PhD, FACS:

faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

Fátima M. Matos, MD, PhD:

faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

PROGRAM DESCRIPTION: The anterior commissure has great interest in laryngeal oncology. In its midline there is a higher susceptible to the invasion of cartilage by cancer due to the lack of perichondrium. Larynx cancer can be treated by surgery and radiotherapy and this applies to early tumors involving the anterior commissure. In patients who undergo radiotherapy, a worse rate of local control can be noticed when there is invasion of the anterior commissure. Other therapeutic alternative to early larynx cancer that invades the anterior commissure is open vertical frontolateral laryngectomy which includes part of midline cartilage within the surgical margin, however, in recent decades, it has been replaced by transoral laser procedures. After anatomical, histopathological and imaging review, the different treatment options will be discussed.

Learning Objectives:

To discuss the treatment indications for early laryngeal cancer invading the anterior commissure.
To evaluate the status of invasion of the anterior commissure.
To correlate anatomical, histopathological and image evaluation of the anterior commissure with the treatment approaches.

Moderator(s)

Rogerio A. Dedivitis, MD, PhD

Assistant Professor
University of Sao Paulo School of Medicine
Santos, Sao Paulo, Brazil

Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.
Luiz P. Kowalski, MD

Professor and Chairman
University of Sao Paulo Medical School and A C Camargo Cancer Center
Sao Paulo, Sao Paulo, Brazil

Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

Panelist(s)

Fernando L. Dias, MD, PhD, FACS

Chairman & Chief
Catholic University of Rio de Janeiro; Brazilian National Cancer Institute
Rio de Janeiro, Rio de Janeiro, Brazil

Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.
Fátima M. Matos, MD, PhD

Chief of Head and Neck Surgery Department
Universidade Estadual de Pernambuco
Recife, Pernambuco, Brazil

Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.